| Q40108861 | A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia |
| Q37326649 | A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection |
| Q34665075 | Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia |
| Q36829879 | Acute respiratory distress syndrome caused by Mycoplasma pneumoniae without elevated pulmonary vascular permeability: a case report |
| Q37763011 | Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods |
| Q40234898 | Age-specific Mycoplasma pneumoniae pneumonia-associated myocardial damage in children |
| Q36086497 | An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school in China |
| Q50784291 | An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienna. |
| Q37495299 | Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum |
| Q48207153 | Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity |
| Q55918613 | Antibiotics for acute bronchitis |
| Q57689641 | Antibiotics for acute bronchitis |
| Q24198126 | Antibiotics for acute bronchitis |
| Q24245925 | Antibiotics for acute bronchitis |
| Q33908642 | Antibiotics for acute bronchitis. |
| Q26767481 | Antibody Response to Mycoplasma pneumoniae: Protection of Host and Influence on Outbreaks? |
| Q35191424 | Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis? |
| Q34030959 | Antigen-pulsed bone marrow-derived and pulmonary dendritic cells promote Th2 cell responses and immunopathology in lungs during the pathogenesis of murine Mycoplasma pneumonia |
| Q56112199 | Authors' reply |
| Q34729686 | Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study |
| Q36165742 | Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? |
| Q24801405 | Clinical features of culture-proven Mycoplasma pneumoniae infections at King Abdulaziz University Hospital, Jeddah, Saudi Arabia |
| Q73428787 | Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR |
| Q35922138 | Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae |
| Q33957960 | Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children |
| Q74184805 | Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia |
| Q41482077 | Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples |
| Q35073870 | Cytokine and chemokine transcription profile during Mycoplasma pulmonis infection in susceptible and resistant strains of mice: macrophage inflammatory protein 1beta (CCL4) and monocyte chemoattractant protein 2 (CCL8) and accumulation of CCR5+ Th c |
| Q34580177 | Dendritic cells are the major antigen presenting cells in inflammatory lesions of murine Mycoplasma respiratory disease |
| Q35549349 | Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice |
| Q39887214 | Detection of Mycoplasma pneumoniae by real-time nucleic acid sequence-based amplification |
| Q34453887 | Detection of Mycoplasma pneumoniae in spiked clinical samples by nucleic acid sequence-based amplification |
| Q37851205 | Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay |
| Q39464101 | Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State |
| Q33353887 | Differential expression of lipoprotein genes in Mycoplasma pneumoniae after contact with human lung epithelial cells, and under oxidative and acidic stress |
| Q39633887 | Dual infection with Bordetella pertussis and Mycoplasma pneumoniae in three infants: case reports |
| Q36828136 | Effective treatment strategies for paediatric community-acquired pneumonia |
| Q34548131 | Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections |
| Q56526234 | Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016 |
| Q49820170 | Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015. |
| Q36334084 | Epidemiology and clinical features of segmental/lobar pattern Mycoplasma pneumoniae pneumonia: A ten-year retrospective clinical study |
| Q33568059 | Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study |
| Q37255258 | Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections |
| Q46412044 | Evaluation of 10 serological assays for diagnosing Mycoplasma pneumoniae infection |
| Q42868721 | Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". |
| Q34943465 | Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. |
| Q41142262 | Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections |
| Q54261634 | Evaluation of the Virclia® automated chemiluminescent immunoassay system for diagnosing pneumonia caused by Mycoplasma pneumoniae. |
| Q80625595 | Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl |
| Q34007157 | Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice |
| Q57804593 | Hyperoside inhibits proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae |
| Q41978777 | Identification of P1 variants of Mycoplasma pneumoniae by use of high-resolution melt analysis |
| Q37867679 | Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care |
| Q33960739 | Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods. |
| Q62658670 | Infecciones causadas por Mycoplasma pneumoniae |
| Q26752332 | Infection with and Carriage of Mycoplasma pneumoniae in Children |
| Q89479730 | Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis |
| Q36525637 | Isolation of Mycoplasma pneumoniae from the human urogenital tract |
| Q35968623 | Isothermal Detection of Mycoplasma pneumoniae Directly from Respiratory Clinical Specimens |
| Q37873727 | Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices |
| Q54535598 | Lung function and bronchial responsiveness after Mycoplasma pneumoniae infection in early childhood. |
| Q23922783 | Microbial bioaerosols in the occupational environment: exposure, detection, and disease |
| Q47706191 | Modelling persistent Mycoplasma pneumoniae infection of human airway epithelium. |
| Q35578804 | Molecular Diagnosis of Mycoplasma pneumoniae Respiratory Tract Infections |
| Q41945069 | Molecular detection of Mycoplasma pneumoniae by quantitative real-time PCR in patients with community acquired pneumonia |
| Q44238747 | Multi-system manifestations of Mycoplasma pneumoniae infection in a young patient |
| Q36362965 | Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study |
| Q36582458 | Mycoplasma pneumoniae Epidemiology in England and Wales: A National Perspective. |
| Q35920629 | Mycoplasma pneumoniae and its role as a human pathogen |
| Q92554183 | Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management - a retrospective cohort study in Switzerland |
| Q39327219 | Mycoplasma pneumoniae from the Respiratory Tract and Beyond |
| Q40334428 | Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales. |
| Q36362841 | Mycoplasma pneumoniae infections in Australian children |
| Q33445332 | Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). |
| Q38965947 | Mycoplasma pneumoniae respiratory tract infections among Greek children |
| Q37445186 | Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions--Systematic review and meta-analysis. |
| Q45768830 | Mycoplasma pneumoniae: Innocent Bystander or a True Cause of Central Nervous System Disease? |
| Q44702068 | Mycoplasma pneumoniae: an aetiological agent of acute haemorrhagic oedema of infancy |
| Q36494769 | Mycoplasma pneumoniae: usual suspect and unsecured diagnosis in the acute setting |
| Q34033450 | NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp |
| Q33612900 | NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization |
| Q41154344 | Neurological Complications of PCR-Proven M. pneumoniae Infections in Children: Prodromal Illness Duration May Reflect Pathogenetic Mechanism |
| Q35209593 | New concepts of Mycoplasma pneumoniae infections in children |
| Q37228742 | Pediatric respiratory infections by Mycoplasma pneumoniae. |
| Q33343116 | Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection |
| Q92184196 | Pooled analysis of nuclear acid sequence-based amplification for rapid diagnosis of Mycoplasma pneumoniae infection |
| Q61444360 | Positively interacting strains that co-circulate within a network structured population induce cycling epidemics of Mycoplasma pneumoniae |
| Q33998574 | Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays |
| Q58003638 | Prevalence of Mycoplasma pneumoniae in children in Diyarbakir, the south-east of Turkey |
| Q73902404 | Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR |
| Q37875621 | Rationalised prescribing for community acquired pneumonia: a closed loop audit |
| Q35532530 | Resistance to mycoplasmal lung disease in mice is a complex genetic trait |
| Q37862475 | Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia in Istanbul, Turkey |
| Q52651278 | Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case-control study protocol. |
| Q33757110 | Roles of innate and adaptive immunity in respiratory mycoplasmosis |
| Q42119310 | Severe Mycoplasma disease--rare or underdiagnosed? |
| Q41137747 | Severe childhood Guillain-Barré syndrome associated with Mycoplasma pneumoniae infection: a case series. |
| Q37858428 | Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR |
| Q40327580 | Survey of Mycoplasma pneumoniae in Iranian children with acute lower respiratory tract infections. |
| Q35090589 | THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE |
| Q47724345 | The Role of B Cells in Carriage and Clearance of Mycoplasma pneumoniae From the Respiratory Tract of Mice. |
| Q36100171 | The determinant of periodicity in Mycoplasma pneumoniae incidence: an insight from mathematical modelling |
| Q36924030 | The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. |
| Q54486727 | The role of Mycoplasma in upper respiratory infections. |
| Q38797037 | The role of the PM2.5-associated metals in pathogenesis of child Mycoplasma Pneumoniae infections: a systematic review |
| Q33588658 | Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma |
| Q37884498 | Treatment of acute bronchitis in adults without underlying lung disease |
| Q78685361 | [Evaluation of four commercial immunoglobulin G (IgG)- and IgM- specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections] |
| Q54577309 | [Mycoplasma pneumoniae infections: retrospective study in Basse-Normandie, 1997-2005. Epidemiology--diagnostic utility of serology and PCR for a rapid diagnostic] |
| Q38928031 | Ιnflammatory or septic arthritis associated with mycoplasma pneumonia in children: Two case reports and review of the literature |